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Monoterpenes are liquid hydrocarbons with applications ranging from flavor and fragrance to replacement jet fuel. Their toxic-
ity, however, presents a major challenge for microbial synthesis. Here we evolved limonene-tolerant Saccharomyces cerevisiae
strains and sequenced six strains across the 200-generation evolutionary time course. Mutations were found in the tricalbin pro-
teins Tcb2p and Tcb3p. Genomic reconstruction in the parent strain showed that truncation of a single protein (tTcb3p1-989), but
not its complete deletion, was sufficient to recover the evolved phenotype improving limonene fitness 9-fold. tTcb3p1-989 in-
creased tolerance toward two other monoterpenes (-pinene andmyrcene) 11- and 8-fold, respectively, and tolerance toward the
biojet fuel blend AMJ-700t (10% cymene, 50% limonene, 40% farnesene) 4-fold. tTcb3p1-989 is the first example of successful
engineering of phase tolerance and creates opportunities for production of the highly toxic C10 alkenes in yeast.
Monoterpenes are 10-carbon (C10) terpenes derived from twoC5 isoprene units (1). Traditionally used in the flavor and
fragrance industry, monoterpenes, such as d-limonene, are now
also sought after as precursors for light end components of “drop-
in” jet fuels (2). With the ability to convert simple sugars into a
variety of enantiomerically pure monoterpene products (3–5),
microbial synthesis has the potential to overcome the low yields,
impurities, and high costs associated with conventional chemical
synthesis or extraction frombiological tissues (6). TheC15 sesquit-
erpene farnesene is currently produced via fermentation of Sac-
charomyces cerevisiae for diesel markets (N. Renninger and D.
McPhee, U.S. patent application WO2008045555 A2). Monoter-
penes and sesquiterpenes are both derived from the mevalonate
pathway, indicating that yeast has the potential to provide suffi-
cient carbon, redox power, and energy to produce commercial
quantities of monoterpenes. Unlike sesquiterpenes, however,
monoterpenes are highly toxic. In S. cerevisiae, for example, lim-
onene halts growth at 60mg/liter (2). Sincemaximizing titers is an
absolute requirement for cost-effective production (7), toxicity is
a critical challenge facingmicrobial monoterpene production and
biotransformation (8).
Because monoterpenes are oils, they are sparingly soluble in
water and cause phase toxicity rather thanmolecular toxicity.Mo-
lecular toxicity is caused by water-soluble compounds partition-
ing into the plasma membrane (PM) and interfering with mem-
brane properties (9). Molecular toxicity is proportional to a
solvent’s aqueous concentration and reaches its maximum at a
solvent’s solubility point (i.e., at membrane and water saturation)
(10). Phase toxicity occurs beyond a solvent’s solubility and is
defined as inhibition due to a distinct second phase (2). The mo-
lecular mechanisms of phase toxicity remain poorly understood,
but we have demonstrated that limonene interferes with cell wall
integrity (CWI) rather than membranes in S. cerevisiae (10). Ac-
cordingly, rational strategies for alleviating toxicity, such as ma-
nipulation of membrane fluidity or expression of membrane-
bound solvent pumps, have failed to resolve the problem of phase
toxicity (11).
In the past decade, adaptive laboratory evolution (ALE) (12,
13) has proven to be a successful technique for identifying biolog-
ical solutions to combat alcohol (14, 15) and organic acid (16, 17)
toxicity. Here we used ALE to identify genetic targets to alleviate
phase toxicity. We describe a mutation in a single protein
(tTcb3p1-989) that can serve as a tool for the production ofmonot-
erpenes beyond their inhibitory limits.
MATERIALS AND METHODS
Strains,media, and chemicals.The Saccharomyces cerevisiae strain S288C
(MAT SUC2 gal2malmel flo1 flo8-1 hap1) was used as the parental strain
and was provided by the Australian Wine Research Institute (AWRI),
Adelaide, South Australia, Australia. A list of all strains used in this study
can be found in Table S3 in the supplemental material. tcb3 and tcb2
knockout strains were derived from the BY4741 strain deletion collection
(18). The genotype for the tcb3 strain is MATa his31 leu20 met150
ura30 tcb3::kanMX4, and that for the tcb2 strain is MATa his31
leu20 met150 ura30 tcb2::kanMX4. All chemicals were purchased
from Sigma-Aldrich and were of analytical grade. The biojet fuel blend
AMJ-700t was prepared in a 1-ml stock by mixing 50% (vol/vol) limo-
nene, 10% (vol/vol) cymene, and 40% (vol/vol) farnesene. Unless other-
wise noted, the synthetic medium (CBS) consisted of 2 g/liter sucrose, 5
g/liter (NH4)2SO4, 3 g/liter KH2PO4, 0.5 g/liter MgSO4·7H2O, and the
vitamins and trace metals described in reference 2. Solid YPD medium
consisted of 10 g/liter yeast extract, 10 g/liter polypeptone, and 20 g/liter
sucrose. LM is YPD medium containing 300 mg/liter limonene. CBS
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medium is CBS medium modified by changing the concentration of su-
crose to 5 g/liter and adding 20 mg/liter uracil, 50 mg/liter L-histidine, 50
mg/liter L-methionine, and 100 mg/liter L-leucine.
Adaptive evolution by serial batch passage. The parental strain
(S288C) was transferred from a glycerol stock stored at 80°C and was
grown on solid YPD medium at 30°C. A single colony of the parental
strainwas used to inoculate 10ml ofCBSmedium, and this preculturewas
grown overnight until the mid-exponential-growth phase. The appropri-
ate volume from the preculture was used to inoculate 22 ml of CBS me-
dium in 250-ml Teflon-lined screw-top baffled shake flasks to a target
optical density at 660 nm (OD660) of 0.2. The initial volume of limonene
added to the culture at inoculationwas 1.0l (38mg/liter). Limonenewas
directly added to the culture aseptically using a 10-l glass syringe (Ger-
stel, Mülheim, Germany) immediately after inoculation. The culture was
then incubated at 30°C and 200 rpm (in a Multitron orbital shaker with a
25-mm-diameter throw; Infors HT, Bottmingen, Switzerland) until it
reached mid-exponential phase (OD660, 1 to 2, corresponding to ca. 3
doubling times). For the next round, the appropriate volume of the li-
monene-challenged culture was used to inoculate fresh medium (22 ml)
to a target OD660 of 0.2. After several (2 to 4) transfers at a given limonene
load, the amount of limonene was increased (between 0.2 and 0.5 l [7.6
to 19mg/liter] of additional limonene). After 52 daily sequential passages,
the final limonene load was 5.8 l (222 mg/liter). After each passage, 0.5
ml of culture (in the presence of limonene) was added to 0.5 ml of a 40%
(vol/vol) glycerol solution, and the samples were stored at80°C.
Screening of mutants. Mutants were screened by streaking frozen
glycerol stocks out onto solid LMplates. The 8 to 12 largest single colonies
were subjected to a second competitive growth screen in liquid CBS me-
dium containing 95 mg/liter of limonene. Isolates were precultured in
CBS medium (10 ml) overnight at 30°C (200 rpm), and the appropriate
volume of the preculture was used to inoculate 22 ml of CBS to an OD660
of 0.2 in 250-ml Teflon-sealed screw-top shake flasks. Then 2.5 l of
limonene (95 mg/liter) was added immediately after inoculation, and
growth wasmonitored for 12 h using a Libra S4 spectrophotometer at 660
nm. The mutant with the highest specific growth rate was chosen for
tolerance testing.
Tolerance testing. The evolved and unevolved strains were evaluated
for tolerance of each toxic compound as described in reference 2. Briefly,
cultures were grownuntilmid-exponential phase (OD660,1.0) andwere
then dosed with varying amounts of solvent. The optical density was eval-
uated for the ensuing 6 h. The MIC is defined as the amount of solvent
required to inhibit the specific growth rate by approximately 50% relative
to that of the control strain in the absence of solvents. For fitness tests, 3.6
l (138 mg/liter) of limonene was added to the inoculum (22 ml at an
OD660 of 0.2), and growth wasmonitored as described above. The ratio of
the OD660 at 12 h to the OD660 at 0 h was used as a relative fitness metric
for solvent tolerance (19). CBS medium containing 5 g/liter sucrose was
used in all tolerance tests (CBS medium was used for the tcb3 strain,
and the fitness of the reconstructed tTcb3p, TB516, S288C, and BY4741
strains was also tested in CBSmedium [see Table S7 in the supplemental
material]). All tolerance tests were performed in biological triplicate for
each compound and strain.
DNA isolation. All DNA was isolated according to the method of
Otero et al. (20)with the followingmodifications. A total of 5ml of culture
was harvested in mid-log phase (OD, 3) at an RCF of 16,000  g and
25°C, washed twice with distilled water, pelleted, and resuspended in 800
l of lysis buffer (1% SDS, 50 mM EDTA, 0.1 M Tris-HCl [pH 7.5]). The
suspension was transferred to FastPrep screw-cap tubes containing 1 g of
0.5-m acid-washed beads and 100l of 5 MNaCl. To lyse the cells, four
bead-beating cycles (30 s of beating followed by 1min on ice) were carried
out in a mechanical bead beater (JohnMorris Scientific, Pty Ltd., Sydney,
Australia). The suspension was then harvested (RCF, 16,000 g; 4°C) for
15 min, and the resulting clear liquid (ca. 800 l) was transferred to new
1.5-ml UltraClean tubes (Mo Bio, Carlsbad, CA). Next, 777 l of a chlo-
roform–isoamyl alcohol (24:1) mixture was added and was incubated at
25°C for 30min with gentle rocking. Themixture was then pelleted for 15
min (RCF, 16,000 g; 25°C), and the top, aqueous layer was transferred
to a new UltraClean tube, mixed with 70% (vol/vol) isopropanol, and
centrifuged (RCF, 16,000 g; 25°C) for 6 min. The isopropanol suspen-
sion was decanted, and the pellet was resuspended in 70% ethanol. The
ethanol suspension was centrifuged (RCF, 16,000  g; 25°C) for 6 min,
and the pellet was allowed to dry for 45min. The pellet was resuspended in
50l of DNAandRNA-freewater containing 100g/ml RNaseA andwas
incubated at room temperature for 30 min.
Genome sequencing. Paired-end (100-bp) genomic DNA libraries
were generated using TruSeq DNA sample preparation kits according to
the manufacturer’s instructions (Illumina, San Diego, CA). Genomic
DNA was sheared to a target insert size of 300 to 400 bp using a Covaris
ultrasonicator (model M220; Covaris Inc., Woburn, MA). Whole-ge-
nome resequencingwas performed by theQueenslandCentre forMedical
Genomics (Institute for Molecular Bioscience, University of Queensland,
Brisbane, Australia) on an Illumina HiSeq 2500 system (HiSeq Control
Software, version 2.0.5; RTA 1.17.20) by following the standard rapid
sequencing workflow of cluster generation and sequencing by synthesis
(SBS). Initially, libraries were loaded onto an Illumina cBot instrument
for template hybridization and initial extension steps using the TruSeq
Rapid Duo cBot sample loading kit (catalog no. CT-402-4001). Flow cells
were then moved to the HiSeq 2500 instrument to complete cluster gen-
eration and sequencing using the TruSeq rapid paired-end cluster kit
(catalog no. PE-402-4001) and the TruSeq rapid SBS kit (200 cycles) (cat-
alog no. FC-402-4001) according to the manufacturer’s publications.
Samples were loaded at a concentration of 6 pM, and a total of 209 cycles
of sequencing, consisting of two 101-bp reads and a single 7-bp index
sequence, were completed.
For mutation analysis, the default settings in Bowtie 2 (version 2.0.2)
and samtools (version 0.1.18) were used in alignment and mapping (21).
The input paired-end reads (101 bp) were trimmed on the basis of quality
(3 bases from the start and 23 bases from the end) to produce 75-bp reads
for each sample. The results from themappingwere used to identify single
nucleotide polymorphisms (SNPs) and insertions and deletions (indels)
between the mutant and reference strain. The initial sequencing results
and mutations, which were identified according to the default software
settings mentioned above, are listed in Table S1 in the supplemental ma-
terial. The mutations in Table S1 were further filtered, and alignments
were viewed using Integrative Genomics Viewer (IGV) software (22). A
mutation was called only if it met the following criteria: the mutation
occurred in a coding region, and SNPs and indels were filtered using a
Phred-like consensus quality of 	30. For SNPs, the coverage depth was
10, and	95% of the base pair reads harbored the mutation. For indels,
if the number of reads with an indel was less than the number of reads
without it, that indel was filtered out. For example, initially, 39 mutations
were identified in evolved strain TB302; however, after filtering, only 10
mutations occurred in coding regions, and 2 of them met the filtering
criteria. Annotation and prediction of the effects caused by the mutations
were carried out using the snpEff program (version 3.1) (23). The data
were run against the Ensembl build (EF4.68) of the S288C reference ge-
nome and were used as input in the snpEff database.
Genomic reconstruction.Themutations inPDR3 (Q763L) andTCB3
(frameshift causing truncation at amino acid 989) were introduced into
the parental strain (S288C) using the amdSYM recyclable dominant
marker cassette (24). The reconstructed S288C strain harboring the mu-
tation in TCB3 resulting in truncation at amino acid 989 is referred to
below as the tTcb3p strain. The details of construction can be found in the
supplemental material (see Tables S2 and S8 in the supplemental material
for primers and SNP reconstruction efficiency, respectively). A gain-of-
function assay was performed for all reconstructed strains. As described
above, relative fitness in the presence of limonene, cymene, 
-pinene,
myrcene, and AMJ-700t was investigated for the parental strain, an
evolved strain (TB516), and reconstructed strains.
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Fluorochrome staining and flow cytometry. For the S288C and
tTcb3p strains, cell viability and cell wall damage were assessed using the
vital staining dye propidium iodide (PI) and the cell wall binding dye
calcofluor white (CFW). Briefly, cells were treated with an inhibitory
amount of limonene (138 mg/liter) during the mid-log-growth phase (20
g/liter CBS medium). After 2 h of treatment, cell viability was tested (as
described in reference 2), and cell wall staining was performed (as de-
scribed in reference 10), in biological triplicate.
Transcriptomics. Total RNA was isolated from S288C and tTcb3p cul-
tures during the mid-exponential-growth phase described previously (10).
For control (no limonene) and limonene-challenged (107mg/liter) cultures,
approximately 10 ml of culture was quickly pelleted (RCF, 17,572 g) for 2
min at 4°C, immediately resuspended in 2 ml of RNAlater solution (Life
Technologies, Carlsbad, CA), and stored at 4°C. The RiboPure-yeast kit
(Ambion, Life Technologies, Carlsbad, CA) was used for total-RNA ex-
traction according to the manufacturer’s instructions, except that bead
beating was used to lyse the cells, as described in reference 10. The RNA
quality was assessed using an Agilent 2100 bioanalyzer and an RNA 6000
Nano kit according to the manufacturer’s methods (Agilent, Santa Clara,
CA). For the single-labeled microarrays (Affymetrix Yeast Genome 2.0
array), samples were labeledwith 100 ng of total-RNA startingmaterial by
using the Affymetrix IVT Express labeling assay according to the manu-
facturer’s instructions (Affymetrix, Santa Clara, CA). For hybridization, 4
g of fragmented biotin-labeled cRNA was hybridized to each array at
45°C for 16 h at 60 rpm in an Affymetrix hybridization oven. Arrays were
washed according to the manufacturer’s instructions using an Affymetrix
GeneChip Fluidics Station 450. Arrays were scanned using an Affymetrix
S3000 scanner. The entire microarray processing procedure was per-
formed at the Ramaciotti Centre for Gene Function Analysis (University
of New South Wales, Sydney, Australia). Analysis of differentially ex-
pressed genes and gene set analysis (GSA) were carried out in R using the
default values in the Piano package (25). All analysis was performed in
biological triplicate.
Cell wall proteomics. The total cell wall extracts were isolated from
S288C (parental strain) and tTcb3p cultures during themid-exponential-
growth phase. Cultures were inoculated to a startingOD660 of 0.1 in 22ml
of CBS medium (5 g/liter sucrose) and were allowed to grow to an OD660
of 1.0 in the absence or presence of limonene challenge (107 mg/liter).
Approximately 20ml of culturewas pelleted (RCF, 4,025 g; 5min; room
temperature), washedwith sterile water, snap-frozen by quickly submerg-
ing the sample in dry ice for 2 min, and stored at80°C. Cell wall protein
was extracted by the method described in reference 26. Briefly, yeast cells
were lysed with a bead beater; insoluble cell wall material was stringently
washed; N-glycans were released with endo-
-N-acetylglucosaminidase
H (endo H); and deglycosylated proteins covalently linked to the cell wall
polysaccharide were digested with trypsin. Peptides were desalted with C18
ZipTips (Millipore) and were detected by liquid chromatography (LC)-elec-
trospray ionization (ESI)-tandem mass spectrometry (MS-MS) with a
Prominence nano LC system (Shimadzu) and a TripleTOF 5600 mass spec-
trometer with a Nanospray III interface (AB Sciex). For information-
dependent acquisition (IDA), analyses were performed as described pre-
viously (27). Identical LC conditions were used for SWATH (sequential
window acquisition of all theoretical mass spectra)-MS, with anMS–time
of flight (TOF) scan from an m/z of 350 to an m/z of 1,800 for 0.05 s,
followed by high-sensitivity information-independent acquisition with
26m/z isolation windows, with 1m/z window overlap, for 0.1 s across an
m/z range of 400 to 1,250. The overall SWATH method is described in
reference 28 and has been used successfully for proteomic quantification
in yeast and other tissues without the use of wild-type–versus–wild-type
statistical comparisons (29, 30). Collision energy was automatically as-
signed by Analyst software (AB Sciex) based onm/z window ranges. Pro-
teins were identified from IDA data using ProteinPilot software (AB
Sciex) as described previously (27). False-discovery-rate analysis using
ProteinPilot was performed on all searches. Peptides identified with
	99% confidence and with a local false-discovery rate of1% were sub-
jected to further analysis. S. cerevisiae cell wall proteins identified in these
discovery data were used as the spectral library for analysis of SWATH
MS-MS data using the SWATH processing script within PeakView, ver-
sion 1.2 (AB SCIEX). The fragment ion peak area was used for quantifi-
cation. TheMSstats software package (31) was used for statistical analysis
in R. The statistical significance cutoff was set at a P value of 0.05. All
procedures were performed in biological triplicate.
Sequencing, transcriptome, and proteome data are available online
(http://pathway.aibn.uq.edu.au/S288c/).
RESULTS
Evolved mutants show improved tolerance of limonene. Serial
batch passaging was used to isolate limonene-tolerant yeast
strains. The parental S288C strain underwent 52 daily sequential
transfers under limonene stress. The limonene load increased
from 38 mg/liter to 222 mg/liter. Tolerant strains were isolated as
single colonies on plates during the adaptive evolution process
and were tested for limonene tolerance. Two strains were isolated
between generations 100 and 200, and four strains were isolated at
200 generations. Two tests were used to examine the improved
fitness. The MIC (Table 1; see also Fig. S1 in the supplemental
material) and relative fitness (Fig. 1) were measured for each
strain and were compared to those of the parent. Relative fitness
was defined as the ratio of the cell density (expressed as theOD660)
at 12 h to the cell density at 0 h under limonene exposure. All of the
evolved strains showed at least a 1.8-fold increase in the MIC
(Table 1) and at least a 9-fold increase in relative fitness in the
presence of limonene (Fig. 1). Themaximum relative fitness score
(10.9  1.6) was achieved at 120 generations (strain TB302) and
did not increase significantly for later generations (generations
160 to 200 [Fig. 1]). In the absence of limonene, the maximum
fitness score was 23.4 0.4. For all strains and all tolerance tests,
cell viability remained above 90% after 12 h of incubation (see
Table S1 in the supplemental material). These results show that
adaptive evolution employing serial batch transfer under constant
limonene challenge was successful at isolating limonene-tolerant
phenotypes.
Identification of mutations by whole-genome sequencing.
Six resistant strains were isolated across the evolutionary time
course in order to identify targets for genetic engineering. Muta-
tions were identified by whole-genome resequencing, and each
genome was compared with that of the parental strain, which was
also sequenced and contained no mutations. For each evolved
strain, we first identified all mutations occurring in coding re-
gions. A summary of the sequencing results is presented in Table
S1 in the supplemental material, and all of the mutations for each
strain are listed in Table 1. The selection criteria for mutation
calling are described in Materials and Methods. All resistant
strains had a mutation (Q763L) in PDR3, while all strains with
maximum fitness scores harbored an indel in either TCB2 (dele-
tion of amino acids 314 to 316 [strain TB302, isolated at 120 gen-
erations]) or the closely related gene TCB3 (frameshift at bp 2966,
resulting in the truncation of the protein to 989 amino acids) (Fig.
1). Considering that all of the other mutations found (Fig. 1 and
Table 1) differed among the evolved strains, we assumed that these
were passenger mutations arising from genetic drift and decided
to focus our engineering efforts on the PDR3 andTCB3mutations
only. The genome data are available for download at http:
//pathway.aibn.uq.edu.au/S288c/.
Genomic reconstruction of the limonene-tolerant pheno-
type. We next constructed single and double mutations for the
Brennan et al.
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PDR3 (Q763L) and TCB3 (frameshift resulting in truncation to
989 amino acids) genes in the parental strain and investigated the
relative fitness of these mutants in a gain-of-function assay. A
gain-of-function assay investigates whether a mutation confers a
phenotype by reconstructing the mutation in the parent strain as
opposed to evaluating the phenotype by knocking out genes sys-
tematically in an evolved strain. While the single base change
pdr3Q763L conferred no significant improvement in fitness over
the parental strain, the tcb3-989 mutation (leading to truncated
protein tTcb3p1-989) increased limonene fitness 9-fold, and the
strain with thismutation showed no statistical difference from the
evolved strain (Fig. 2). The pdr3Q763L tcb3-989 double mutant had
a relative fitness score of 11.5  0.5, which did not differ signifi-
cantly from the fitness scores achieved by the evolved mutants or
the TCB3 single mutant (Fig. 2). The reconstructed double mu-
tant carrying both the TCB3 and TCB2mutations (tcb3-989 tcb2-
316) showed no increase in fitness over that of the single
tTcb3p1-989 mutant (see Table S7 in the supplemental material).
These data revealed that the mutation in tTcb3p1-989 alone could
confer limonene tolerance.
TABLE 1 Summary of limonene MICs and mutations found in evolved strains
Strain Gena
MICb
(mg/liter) FCc Mutation Gene Function
S288C 0 69
TB302 120 130 1.9 SNP (Q763L) PDR3 Transcriptional activator of the pleiotropic drug resistance network
Indel (deletions of E314, V315, P316) TCB2 ER protein located in the mother and daughter bud, involved in
ER-plasma membrane tethering
TB405 160 122 1.8 SNP (Q763L) PDR3 Transcriptional activator of the pleiotropic drug resistance network
Indel (frameshift; truncation at 989 aa) TCB3 ER protein located in the mother and daughter bud, involved in
ER-plasma membrane tethering
Indel (frameshift; truncation at 192 aa) TSA1 Thioredoxin peroxidase
SNP (Q192G)
SNP (D380H) UBP11 Ubiquitin-specific protease
TB511 200 138 2.0 SNP (Q763L) PDR3 Transcriptional activator of the pleiotropic drug resistance network
Indel (frameshift; truncation at 989 aa) TCB3 ER protein located in the mother and daughter bud, involved in
ER-plasma membrane tethering
Indel (frameshift; truncation at 192
aa), SNP (Q192G)
TSA1 Thioredoxin peroxidase
SNP (W580S) KSP1 Serine/threonine protein kinase
SNP (nonsense; Q1014*) PSE1 Karyopherin/importin that interacts with the nuclear pore complex
SNP (L84S) RPL30 Ribosomal 60S subunit protein
TB516 200 138 2.0 SNP (Q763L) PDR3 Transcriptional activator of the pleiotropic drug resistance network
Indel (frameshift; truncation at 989 aa) TCB3 ER protein located in the mother and daughter bud, involved in
ER-plasma membrane tethering
Indel, SNP (Q192G) TSA1 Thioredoxin peroxidase
SNP (R159T) CDC34 Ubiquitin-conjugating enzyme; regulates cell cycle progression by
targeting key substrates for degradation
TB517 200 145 2.1 SNP (Q763L) PDR3 Transcriptional activator of the pleiotropic drug resistance network
Indel (frameshift; truncation at 989 aa) TCB3 ER protein located in the mother and daughter bud, involved in
ER-plasma membrane tethering
SNP (nonsense; Q1014*) PSE1 Karyopherin/importin that interacts with the nuclear pore complex
SNP (L84S) RPL30 Ribosomal 60S subunit protein
TB519 200 138 2.0 SNP (Q763L) PDR3 Transcriptional activator of the pleiotropic drug resistance network
Indel (frameshift; truncation at 989 aa) TCB3 ER protein located in the mother and daughter bud, involved in
ER-plasma membrane tethering
SNP (G826R) SIP3 Transcription cofactor; acts through interaction with DNA-bound
Snf1p
SNP (L127F) YMR102c Protein of unknown function
a Gen, generation.
b Defined as the amount of limonene required to inhibit the specific growth rate by approximately 50% relative to the growth rate of the same strain in the absence of solvents.
c FC, fold change (ratio of the MIC for the evolved strain to the MIC for strain S288C).
FIG 1 Summary of the relative fitness and genetic mutations of the evolved
strains. Relative fitness is defined as the ratio of the cell density (expressed as
the OD660) at 12 h to the cell density at 0 h during limonene exposure (138
mg/liter). Error bars represent 1 SD above the mean for biological replicates
(n 3). The location of each mutation can be found in Table 1.
Engineering Tolerance of Monoterpenes in Yeast
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Given that the TCB3mutation encoded a truncated version of
Tcb3p, we asked whether this mutation resulted in a nonfunc-
tional protein and whether limonene resistance was due to effec-
tive loss of Tcb3p. A TCB3 knockout strain, however, showed no
enhanced tolerance and matched the fitness of S288C (Fig. 2a,
tcb3). This demonstrates that, despite encoding a truncated pro-
tein, the evolved tTcb3p strain has a gain-of-function mutation.
This result further highlights the advantage of ALE over other
approaches; traditional screening of knockout libraries would not
have identified TCB3 as a viable target.
Next, we investigated the potential biological implications of
truncating Tcb3p. Normally, Tcb3p resides exclusively in the cor-
tical endoplasmic reticulum (cER) and tethers the cER to the
plasmamembrane (PM) (32). It was recently demonstrated, how-
ever, that a truncated version of Tcb3p, lacking the C2 lipid bind-
ing domains (Fig. 2b, WT Tcb3), caused Tcb3p to untether itself
from the PM and colocalize in the perinuclear endoplasmic retic-
ulum (nER) and the cER. We investigated whether limonene re-
sistance was associated with this dual localization property. We
created a version of Tcb3p that was similarly truncated at position
531, which resulted in limonene tolerance (Fig. 2a, tcb31-531).
These data strongly indicate that the gain of function and the
resistant phenotype observed may be linked to the ability of
tTcb3p to reside in both the cER and nER.
FIG 2 (a) Relative fitness of strains reconstructedwithmutations in the presence of limonene. Relative fitness is defined in the legend to Fig. 1. The evolved strain
score represents the average fitness score for all evolved strains (TB302 through TB519). Beneficial mutations in PDR3 and TCB3were constructed in the parent
strain (S288C). Error bars represent 1 SD from themean for biological replicates (n 3). Significance was determined by one-way analysis of variance to correct
for multiple comparisons relative to the S288C result (****, P 0.001; ns, not significant [P	 0.05]). (b) Diagram of S288C and the tTcb3p1-989 mutant. The
number of amino acids is given below each diagram. WT, wild type; TMD, transmembrane domain; SMP, synaptotagmin-like-mitochondrial lipid-binding
protein; C2, lipid binding domain.
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Alternatively, limonene resistancemay also be due to the loss of
the tricalbin complex. Tcb2p forms a heterocomplex with Tcb3p
(and Tcb1p) by binding to the C-terminal portions of tricalbins 1
and 3 (33).With theC terminus of Tcb3p absent in both truncated
versions (ending at position 989 or 531), we questioned if limo-
nene resistance was associated with the breakdown of the Tcb2p-
Tcb3p tricalbin complex. A full knockout of Tcb2pwas effective at
increasing limonene resistance (Fig. 2a, tcb2 [fitness score,
7.86  1.27]). In addition to the dual localization property of
Tcb3p in the ER, the absence of the tricalbin complex may also
contribute to the resistance mechanism.
Changes to CWI, the transcriptome, and the proteome. We
demonstrated previously that limonene damages the cell wall
(10). Hence, we explored if the tTcb3p1-989 mutation improved
the structural integrity of the cell wall during limonene stress. Cell
wall integrity (CWI) wasmeasured using calcofluor white (CFW),
a fluorochrome that binds to cell wall polysaccharides (34). Cells
with damaged walls show increased sensitivity and a higher mean
fluorescence intensity (MFI) when stained with CFW (10). As
shown in Fig. 3c, 59% 6%of S288C cells had substantial cell wall
damage after limonene exposure. This was a 10-fold increase in
the proportion of damaged cells over that for the untreated control
FIG 3 Histograms representing the variation in fluorescence emitted from S288C (wild-type) and tTcb3p1-989 mutant cells. (a and d) Unstained cells; (b and e)
unexposed control cells stained with CFW; (c and f) cells stained with CFW after 2 h of limonene exposure. The mean fluorescence intensity (MFI) and mean
percentage of damaged cells (Pop %) SD are reported for biological replicates (n 3).
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(6%  1% [Fig. 3b]). In contrast, cells harboring the tTcb3p1-989
single mutation showed a much smaller, 2-fold increase in cell
wall damage after limonene treatment (24% 1% versus 11%
1% of cells damaged [Fig. 3e and f]). In addition, loss of cell wall
integrity affected cytokinesis, and the number of defects in cell
separation was found to be higher in treated S288C cells than in
treated tTcb3p1-989 cells (see Fig. S3 in the supplementalmaterial).
These results demonstrate that the tTcb3p1-989 protein has the
ability to preserve cell wall integrity during limonene treatment.
In wild-type strains, limonene exposure causes a substantial
transcriptional response (10). When strains were challenged with
limonene, the total number of differentially expressed genes (29
genes) (see Table S4 in the supplemental material) was substan-
tially lower for the tTcb3p1-989 strain than for strain S288C (453
genes reported in reference 10). This is partly explained by the
large number of regulated genes associated with growth defects in
S288C (10). The tTcb3p1-989 mutant showed very small perturba-
tions to growth when challenged with limonene, and thus, the
smaller gene list was not surprising (see Fig. S2 in the supplemen-
tal material). However, roughly 30% of genes on the upregulated-
gene list are associatedwith cell wall repair (see Table S4). In yeast,
the CWI signaling pathway is responsible for responding to cell
wall damage (35). The CWI cascade was highly upregulated in
S288C (10) but was not induced in mutant cells (Fig. 4). In
tTcb3p1-989 cells, limonene stress induced genes associated with
cell wall maintenance, which are not part of the CWI signaling
pathway. ECL1, SMP1, TIR2, and YPL277C were upregulated in
the mutant but not in S288C, and only three upregulated genes
were shared by the strains (YGP1, FIT2, FIT3). Several genes in-
volved in iron ion homeostasis were also upregulated (SIT1,
HMX1, ARN1, FRE5, TIS11). This response was similarly ob-
served for exposed S288C cells (10). Global transcript analysis was
also performed in the absence of limonene to investigate expres-
sion patterns directly caused by the TCB3 mutation (comparing
gene expression by the tTcb3p1-989 mutant with that by S288C).
However, no genes were differentially expressed.
We also characterized the direct impact of the tTcb3p1-989 mu-
tation on cell wall protein abundance during limonene shock. For
untreated cells, Ygp1pwas the only protein induced in themutant
relative to S288C (see Table S5 in the supplemental material). The
cell wall proteins Plb1p, Plb2p, Ecm33p, Tos1p, Cis3p, andUth1p
were found to be lower in abundance in themutant than in S288C
(see Table S5). During limonene challenge, the cell wall proteins
Pbl2p, Cis3p, and Ccw14p were induced in the mutant but were
absent in the parental strain. Gas3p, Yap7p, and Cwp1p were the
only common regulated cell wall proteins found during limonene
stress (Fig. 4). Taken together, these data demonstrate that both
the TCB3 mutation and limonene affect protein secretion or cell
wall biosynthesis, but in different ways. The underlying mecha-
nisms, however, remain unresolved.
Tolerance toward terpenes other than limonene.To test if the
tTcb3p1-989 mutation also conferred tolerance toward terpenes
other than limonene, the tolerance assays were repeated with a
range of compounds. Fitness in the presence of 
-pinene and
myrcene increased significantly (11- and 8-fold, respectively) over
that of S288C (Fig. 5), and the fitness of the reconstructed strain
matched, or was improved over, that of the evolved strain
(TB516). Themutant showednofitness increase in the presence of
the aromatic monoterpene cymene (Fig. 5) or of other aromatics
(xylene, toluene, and styrene [see Table S6 in the supplemental
material]). A 4-fold increase was observed in tolerance of a ter-
pene jet fuel precursor mixture (AMJ-700t) (Fig. 5). AMJ-700t
contains, by volume, 50% limonene, 10% cymene, and 40%
farnesene. After a single hydrogenation step, AMJ-700t can be
converted to the paraffin jet fuel mixture AMJ-700 (50% limo-
nane, 10% cymene, and 40% farnesane), which was successfully
used in a demonstration flight during Rio20 in June 2012 (42).
DISCUSSION
Strains with improved fitness in the presence of limonene and
other toxic terpenes were identified through adaptive evolution
employing serial batch passaging (Fig. 1 and 5). In typical ALE
approaches, the final strain is sequenced and is compared with the
parent strain (19). Here we resequenced genomes across the evo-
lutionary time course and constructed a spatiotemporal represen-
tation of the environmentally selected mutations. This enabled us
FIG 4 Cell wall transcriptome and proteome responses during limonene stress. Venn diagrams represent overlaps and differences in cell wall gene expression
(upregulated genes only) and protein abundance between S288C and tTcb3p1-989 cells. Cell wall genes upregulated in S288C are from the work of Brennan et al.
(10). Genes upregulated in the tTcb3p1-989 mutant, and cell wall proteins with changes in expression in S288C or the tTcb3p1-989 mutant, were analyzed in this
study.
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to judge more precisely which mutations were potentially signifi-
cant. For example, if TB511 had been the only final strain se-
quenced, then six potential gene targets would have had to been
examined. Alternatively, we captured mutations in TCB2/TCB3
and PDR3 that occurred early on in ALE (Fig. 1). When the final
evolved strains (TB511 to TB519) were analyzed, this information
was useful for deciding which genes to focus on for strain devel-
opment.
For example, a mutation in PDR3, encoding the transcrip-
tional activator for the pleiotropic drug resistance network, was
found in every evolved strain (Fig. 1). Upregulation of ABC trans-
porters during limonene stress has been observed previously, but
overexpression of these failed to improve limonene tolerance (11).
Similarly, we observed that a genomic reconstruction of the mu-
tation (pdr3Q763L) in S288C did not significantly improve fitness
(Fig. 2a). The transporters may address low levels of molecular
toxicity while failing to address the major issue of phase toxicity.
Mutations in the tricalbin (“tri” for three, “ca” for calcium, “l”
for lipid, and “bin” for binding) (33) protein Tcb2p or Tcb3pwere
found in all evolved strains with maximum fitness scores (Fig. 1).
A mutation in TCB2 was found early (at 120 generations; strain
TB302 in Fig. 1), while an indel in TCB3 causing truncation at
position 989 was found at later time points. Genomic reconstruc-
tion of tcb3-989 in S288C revealed that the limonene-resistant
phenotype can be achieved by this single point mutation. The
correlation of genotype with phenotype is generally a complex
problem (36). To our knowledge, no previous report has de-
scribed a single pointmutation that confers tolerance toward toxic
next-generation biofuels on yeast.
While the specific role of the TCB3 mutation remains unre-
solved, this work shows that it is involved in preventing cell wall
damage. Limonene stress causes reduced cell wall integrity in
S288C (Fig. 3c) and strongly induces the cell wall integrity signal-
ing pathway (Fig. 4). In the reconstructed strain, limonene did not
severely affect cell wall integrity (Fig. 3f), and there was no activa-
tion of CWI signaling during limonene shock (Fig. 4). Limonene
had different and, in several instances, opposite effects on the cell
wall proteome, while fewer genes involved in cell wall mainte-
nance and biogenesis were affected in the tTcb3p1-989 variant (Fig.
4). The mutation may directly enhance cell wall resilience, e.g., by
increasing the degree of cross-linking. For example, Cis3p and
Ccw14p serve as structural stabilizers covalently linking cell wall
polysaccharides (37, 38) and were upregulated in the mutant but
not in S288C (Fig. 4). Enhanced cell wall protection in themutant
was evident after investigation of budding patterns during limo-
nene stress (see Fig. S3 in the supplemental material).
In addition to biofuel applications, this work has revealed new
insights into the biological function of tricalbin proteins, which
are homologous to synaptotagmins and SNARE proteins inmam-
malian cells (39). Little is known about the biological function of
tricalbins other than that they can tether the ER to the plasma
membrane (32, 39). This study links tricalbins to the regulation of
cell wall integrity, which has not been reported previously. The
data also show thatwhen tricalbins act as heterodimers rather than
as free proteins, different biological behavior is observed in vivo.
This work serves as a foundation for future studies to explore the
mechanism and functional implications of this distinction be-
tween complexed and noncomplexed tricalbins.
Commercial-level biological production of monoterpenes de-
pends on solving the toxicity problem. Currently, monoterpene
olefin production in yeast is still in the developmental stage, and
titers have yet to reach inhibitory levels (60 to 200 mg/liter). As
strain engineering leads to better-performing strains, phase toxic-
ity will become a major constraint. Monoterpenes passively dif-
fuse in and out of cells (40, 41), which means that high endoge-
nous cellular production will drive transport to the extracellular
environment, increasing the solvent phase and enhancing phase
toxicity effects. This is the first example of successful engineering
of phase tolerance and the first report of a single point mutation
that confers tolerance of a range of toxic next-generation biofuels.
Given the simplicity of the Tcb3p mutation, our work provides a
straightforward strategy that can be tailored to any yeast strain to
increase tolerance, with direct applications to biocatalysis or bio-
transformation of toxic alkenes.
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FIG 5 Relative fitness in the presence of terpenes other than limonene. S288C,
an evolved strain (TB516), and the reconstructed tTcb3p1-989 strain were sub-
jected to relative fitness assays for 
-pinene (198 mg/liter), myrcene (361 mg/
liter), cymene (140 mg/liter), and AMJ-700t (225 mg/liter). AMJ-700t con-
tains, by volume, 10% cymene, 50% limonene, and 40% farnesene. Control
bars represent no exposure. Relative fitness is defined in the legend to Fig. 1.
Error bars represent 1 SD from the mean for biological replicates (n 3).
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